Back to the main directory
Press Release
- Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device by GlobeNewsWire
- Aquestive Therapeutics Announces FDA Acceptance of New Drug Application and PDUFA Date for Anaphylm™ for the Treatment of Severe Allergic Reactions by GlobeNewsWire
- Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025 by GlobeNewsWire
- Portillo’s Adds Veteran Restaurant Leader Gene Lee to Board of Directors by GlobeNewsWire
- Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio by GlobeNewsWire
- Abcourt recoupe 4,1 g/t d’or sur 11 mètres en rainure sur l’ancien décapage de Cambior, prolonge la zone minéralisée sur maintenant 300m de long dans le secteur Cartwright du projet Flordin et présente une mise à jour corporative by GlobeNewsWire
- NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6 by GlobeNewsWire
- RYVYL Appoints Industry Veteran Brett Moyer to Its Board of Directors by GlobeNewsWire
- Aurora Spine Surpasses 1,500 Successful Surgeries Using DEXA-C™ by GlobeNewsWire
- TEGNA Announces Major Local News Expansion: Adding More than 100 Hours of New Daily Programming Across 50+ Markets by GlobeNewsWire
- Discovery Announces Management Appointments by GlobeNewsWire
- Transactions under Novonesis’ share buyback program by GlobeNewsWire
- Completion of conversion of A shares to B shares in accordance with the articles of association and information on adjusted number of voting rights and share capital by GlobeNewsWire
- ParaZero Demonstrates 50 Successful DropAir Deployments as Part of a Decisive Reproducibility Test by GlobeNewsWire
- STMicroelectronics Announces Status of Common Share Repurchase Program by GlobeNewsWire
- Changes in Nokia Corporation's own shares by GlobeNewsWire
- MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor Co-agonist Prodrug for the Treatment of Obesity by GlobeNewsWire
- Extendicare Announces June 2025 Dividend of C$0.042 per Share by GlobeNewsWire
- X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA) by GlobeNewsWire
- Crinetics Pharmaceuticals to Host R&D Day on June 26, 2025 by GlobeNewsWire
- Verizon to report 2Q earnings July 21, 2025 by GlobeNewsWire
- Windtree Announces Publication of Istaroxime Positive Phase 2 SEISMiC B Study by GlobeNewsWire
- Critical Metals Corp Secures US$120,000,000 LOI for a 15-Year Term Loan From the US Federal Government Bank (EXIM Bank) for the Development of its Tanbreez Rare Earth Project in Greenland by GlobeNewsWire
- PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years by GlobeNewsWire
- Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule by GlobeNewsWire